title: The effect of alpha interferon therapy and short-interval intradermal administration on response to hepatitis B vaccine in haemodialysis patients.
authors.forename: C
authors.initials: C
authors.lastname: Ozener
authors.forename: A S
authors.initials: AS
authors.lastname: Fak
authors.forename: E
authors.initials: E
authors.lastname: Avşar
authors.forename: S
authors.initials: S
authors.lastname: Cinar
authors.forename: R
authors.initials: R
authors.lastname: Lawrence
authors.forename: E
authors.initials: E
authors.lastname: Akoğlu
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage; D000328:Adult; D005260:Female; D006509:Hepatitis B / Q000517:prevention & control; D006510:Hepatitis B Antibodies / Q000096:biosynthesis; D017325:Hepatitis B Vaccines / Q000008:administration & dosage*; D006801:Humans; D007271:Injections, Intradermal; D007370:Interferon Type I / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins; D006435:Renal Dialysis / Q000009:adverse effects
chemical_list: D000276:Adjuvants, Immunologic; C075656:GenHevac B Pasteur; D006510:Hepatitis B Antibodies; D017325:Hepatitis B Vaccines; D007370:Interferon Type I; D011994:Recombinant Proteins